-
Hui Genomics: The first gene therapy drug HG004 was approved as an orphan drug by the US FDA
Major progress of Hui Genomics.
2023-04-06 09:41 -
In the 'internal roll' neural intervention track innovation breakthrough, 3 stenosis ischemia produc...
Sanoshenchang 3 kinds of neurointerventional instruments are the world's first.
2023-04-06 09:40 -
Enbio: Partnered with BioNTech to advance the development of next-generation antibody conjugated dru...
Yingen Biology opens new cooperation.
2023-04-06 09:37 -
Sibiman officially announced the initiation of a Phase III clinical trial of AlloJoin®, an adipose-...
The first stem cell organism to initiate Phase III clinical treatment of knee osteoarthritis in China.
2023-04-06 09:36 -
-
The world's first PD-1 and ADC combination therapy was approved; Combe first quarter net profit pre-...
Market express.
2023-04-06 09:33 -
Yi Neng Pharmaceutical, A leading TCM CXO enterprise, has completed a series of financing of over 10...
The largest financing event in the CXO industry after the epidemic.
2023-03-31 13:54 -
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma
How do new drugs break through, aided by policy alone?
2023-03-31 13:52 -
Meinol's new platform - Bonding Chemistry debut in Shanghai IDC
The 4th IDC2023 Research and Development Forum on New and Improved Drugs (IDC) will be held in Shanghai on March 23-24, 2023.
2023-03-31 13:50 -
Meinol completed the B round financing of over 100 million yuan, and continued to accelerate the ove...
This round of fundraising will be used to meet the growing small molecule drug CDMO business development and commercial production needs of the strate...
2023-03-31 13:48
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
